Wilmington, DE, United States of America

Zixia Feng

This inventor holds 1 USPTO granted patent. Top assignee: The Dupont Merck Pharmaceutical Company. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zixia Feng. Retrieved from https://idiyas.com/inventor/zixia-feng-047x60np

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Zixia Feng

Introduction

Zixia Feng, an accomplished inventor based in Wilmington, DE, has made significant contributions to the field of pharmaceuticals. With a patented invention that showcases his expertise in chemistry, Feng stands out as a key figure in medical advancements.

Latest Patents

Zixia Feng holds a patent for "Amidino and guanidino substituted boronic acid inhibitors." This invention relates to novel α-amino acids and α-aminoboronic acids, as well as corresponding peptide analogs, represented by specific formulae. This groundbreaking work highlights his commitment to developing innovative solutions in the pharmaceutical industry.

Career Highlights

Feng is currently employed by the DuPont Merck Pharmaceutical Company, where he has been involved in various research initiatives aimed at advancing drug development. His role at the company allows him to leverage his expertise in chemistry to contribute to new therapeutic options.

Collaborations

Throughout his career, Zixia Feng has had the opportunity to collaborate with notable colleagues, including Sheng-Lian O Lee and David J Carini. These collaborations have fostered a productive environment for innovative research and development.

Conclusion

Zixia Feng exemplifies the spirit of innovation in the pharmaceutical field. His patent and collaborations reflect a commitment to enhancing medical treatments, making him a valuable asset to the DuPont Merck Pharmaceutical Company and the broader scientific community. As the landscape of drug development evolves, inventors like Feng will continue to play a crucial role in shaping the future of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…